Research synthesisLow evidenceMixed effect size4 studies · 2 beneficial · 2 neutral · 0 harmful
Across 4 studies, the evidence for berberine reducing triglyceride levels is mixed: 2 studies reported beneficial effects (one with moderate effect size, one with small), while 2 high-quality RCTs (one among Chinese men with hyperlipidemia, one among type 2 diabetes patients) found no difference between berberine and placebo, showing neutral small effects. The median study duration was 84 days (12 weeks), and the most-studied dose was approximately 1000–1200 mg/day. The predominant effect direction is mixed (beneficial and neutral), with a small to moderate effect size observed in the beneficial studies.
- Effective dose range: 1000–1200 mg/day
- Studied populations: clinical populations with hyperlipidemia or type 2 diabetes
Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance (2 of 4), and the two neutral RCTs are of higher quality (evidence scores 6–7) than the beneficial meta-analyses (scores 4), suggesting the effect may be smaller or more inconsistent than the beneficial direction implies. Publication bias may also be present, as beneficial meta-analyses tend to be published more readily.
Generated Jun 15, 2026